Oruka Stock Surges Nearly 700% Amid Insider Sale of $687K
Arjun Agarwal, Senior Vice President at Oruka Therapeutics (NASDAQ:ORKA), sold approximately $687,000 worth of shares in June 2026. The stock has surged nearly 454% over the past year and is currently trading near $69 per share.
Tickers: $ORKA
Topics: executive activity SEC filing stock sale